Correlation Between Neuropace and Acutus Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neuropace and Acutus Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Acutus Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and Acutus Medical, you can compare the effects of market volatilities on Neuropace and Acutus Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Acutus Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Acutus Medical.

Diversification Opportunities for Neuropace and Acutus Medical

-0.51
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Neuropace and Acutus is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and Acutus Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acutus Medical and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Acutus Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acutus Medical has no effect on the direction of Neuropace i.e., Neuropace and Acutus Medical go up and down completely randomly.

Pair Corralation between Neuropace and Acutus Medical

Given the investment horizon of 90 days Neuropace is expected to generate 1.67 times more return on investment than Acutus Medical. However, Neuropace is 1.67 times more volatile than Acutus Medical. It trades about 0.07 of its potential returns per unit of risk. Acutus Medical is currently generating about -0.36 per unit of risk. If you would invest  428.00  in Neuropace on August 28, 2024 and sell it today you would earn a total of  638.00  from holding Neuropace or generate 149.07% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy4.24%
ValuesDaily Returns

Neuropace  vs.  Acutus Medical

 Performance 
       Timeline  
Neuropace 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.
Acutus Medical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Acutus Medical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong forward indicators, Acutus Medical is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Neuropace and Acutus Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neuropace and Acutus Medical

The main advantage of trading using opposite Neuropace and Acutus Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Acutus Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acutus Medical will offset losses from the drop in Acutus Medical's long position.
The idea behind Neuropace and Acutus Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules